Advertisement

 KNOXVILLE, Tenn. (AP) -Former Tennessee guard Chris Lofton underwent treatment for testicular cancer after a failed drug test revealed he potentially had a tumor.
Lofton revealed to ESPN.com that he underwent surgery in March 2007 and had four weeks of radiation starting in May.
Lofton was randomly picked during the 2007 NCAA tournament for a drug test that revealed he had high levels of a hormone that serves as an indicator of steroid use or cancer.
The Southeastern Conference's 3-point record holder said in a statement released Thursday that it was a difficult time for him but he's now cancer-free.
Coach Bruce Pearl said Lofton and his family had wanted to keep information about his cancer private throughout the season. Team officials declined to comment further about Lofton's condition, citing HIPPA medical privacy laws.
Lofton was The Associated Press' SEC player of the year as a junior and a second-team All-American. He was a preseason All-American going into his senior season.

NCAAB Headlines

More inNCAAB News  

NCAAB Top Stories

Thumbnail Simmons-less Tigers begin new chapter The Ben Simmons Experience, at least collectively, ultimately went down as a major disappointment for LSU. With head coach Johnny Jones feeling the heat, can...
Thumbnail Cardinals to attack ACC all over again Louisville’s 2015-16 campaign couldn’t have ended on a more ignominious note. This year, however, essentially begins in paradise.
Thumbnail Michigan State ready to get back to business The preliminary matchups for the 2016 Battle 4 Atlantis were revealed yesterday, with Michigan State set to take on St. John’s in the first of three...
Thumbnail Trimble returning to Maryland The Maryland Terrapins got some good news last week as Melo Trimble announced he will be returning to the team for his junior...
Thumbnail Texas to contend in 2016-17? Now with a year at Texas under his belt, can Shaka Smart expect bigger things from the Longhorns in 2016-17?
More inNCAAB Articles  

NCAAB Team Pages

Advertisement